| Literature DB >> 28943315 |
Nan Song1, Zhao-Shan Liu1, Wen Xue1, Zhao-Fang Bai1, Qian-Yi Wang1, Jiang Dai2, Xin Liu1, Yi-Jiao Huang1, Hong Cai1, Xiao-Yan Zhan1, Qiu-Ying Han1, Hongxia Wang1, Yuan Chen3, Hui-Yan Li3, Ai-Ling Li3, Xue-Min Zhang4, Tao Zhou5, Tao Li6.
Abstract
Many infections and stress signals can rapidly activate the NLRP3 inflammasome to elicit robust inflammatory responses. This activation requires a priming step, which is thought to be mainly for upregulating NLRP3 transcription. However, recent studies report that the NLRP3 inflammasome can be activated independently of transcription, suggesting that the priming process has unknown essential regulatory steps. Here, we report that JNK1-mediated NLRP3 phosphorylation at S194 is a critical priming event and is essential for NLRP3 inflammasome activation. We show that NLRP3 inflammasome activation is disrupted in NLRP3-S194A knockin mice. JNK1-mediated NLRP3 S194 phosphorylation is critical for NLRP3 deubiquitination and facilitates its self-association and the subsequent inflammasome assembly. Importantly, we demonstrate that blocking S194 phosphorylation prevents NLRP3 inflammasome activation in cryopyrin-associated periodic syndromes (CAPS). Thus, our study reveals a key priming molecular event that is a prerequisite for NLRP3 inflammasome activation. Inhibiting NLRP3 phosphorylation could be an effective treatment for NLRP3-related diseases.Entities:
Keywords: CAPS; JNK1; NLRP3; inflammasome; phosphorylation; priming
Mesh:
Substances:
Year: 2017 PMID: 28943315 DOI: 10.1016/j.molcel.2017.08.017
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970